High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium
Hainsworth, John D., Shipley, Dianna L., Reeves, James, Arrowsmith, Edward R., Barnes, Edward K., Waterhouse, David M.Volume:
11
Language:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2013.04.014
Date:
September, 2013
File:
PDF, 478 KB
english, 2013